Herceptin become most prescribed biologic with KRW 100 billion

‘Herceptin,’ a breast cancer therapy, has become the only biologic with more than KRW 100 billion prescriptions a year.

CoreZetta(CEO Hong-Ki Lee), a health care big data company, analyzed data about 22 biologics turned in to the Health Insurance Review & Assessment Service, and the analysis showed Trastuzumab(Herceptin) was a drug with the largest prescriptions in 2016.

Then, it was followed...